Characteristics | No. of patients (%) or median (IQR) |
---|---|
Age, years | 52.0 (40.5–66.0) |
Sex, male | 35 (68.6) |
Underlying disease | |
 Malignancy | 28 (54.9) |
  Hematologic | 21 |
  Solid | 7 |
 Solid organ transplant | 18 (35.3) |
  Kidney | 11 |
  Liver | 4 |
  Heart | 2 |
  Lung | 1 |
 Othera | 5 (9.8) |
Immunosuppressive agents used, previous monthb | |
 Steroid only | 18 (35.3) |
 Chemotherapy only | 29 (56.9) |
 Steroid with chemotherapy | 4 (7.8) |
Prednisolone-equivalent dose, mg, if steroid used | 16.1 (6.2–34.7) |
Pneumocystis prophylaxis | 2 (3.9) |
Chest radiography findings | |
 Pleural effusion | 11 (21.6) |
 Radiographic pulmonary pattern | |
  Focal or diffuse alveolar pattern | 24 (47.1) |
  Focal or diffuse interstitial pattern | 5 (9.8) |
  Focal or diffuse alveolar-interstitial pattern | 22 (43.1) |
Laboratory findings on ICU admission | |
 WBC blood cells,/μL | 7960.0 (5320.0–12,225.0) |
  Neutrophils,/μL | 5458.0 (3245.0–10,395.0) |
  Lymphocytes,/μL | 580.0 (324.0–1020.0) |
 Albumin, g/dL | 2.8 (2.4–3.3) |
 CRP, mg/dL | 12.4 (8.2–19.6) |
 PaO2/FiO2 ratio, mmHg | 137.2 (112.8–164.6) |
 D(A-a)O2, mmHg | 39.9 (30.8–52.3) |
Organ failure | |
 Shock | 12 (23.5) |
 Renal failure requiring renal replacement therapy | 1 (2.0) |
Respiratory support on ICU admission day | |
 Mechanical ventilation | 43 (84.3) |
 High-flow nasal cannula | 8 (15.7) |
Severity of illness | |
 SAPS 3 | 48.0 (37.0–57.5) |
 SOFA | 6.0 (5.0–8.0) |